» Authors » Aprajita Mattoo

Aprajita Mattoo

Explore the profile of Aprajita Mattoo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 23
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dieter R, Mattoo A, Hotchkis P, Jaffe I, Weldon E, Berger J, et al.
Nephrol Dial Transplant . 2024 Nov; PMID: 39568065
Background And Hypothesis: Hepatitis C virus (HCV) positive-to-negative kidney transplants (KT) require direct acting antiviral therapy, but the optimal timing and duration remain unclear. We hypothesized that 14-day prophylactic course...
2.
Xu J, Mankowski M, Vanterpool K, Strauss A, Lonze B, Orandi B, et al.
Transplantation . 2024 Oct; 109(3):399-402. PMID: 39477825
No abstract available.
3.
Mattoo A, Jaffe I, Keating B, Montgomery R, Mangiola M
Front Genet . 2024 Oct; 15:1442018. PMID: 39415982
Optimizing immunologic compatibility in organ transplantation extends beyond the conventional approach of Human Leukocyte Antigen (HLA) antigen matching, which exhibits significant limitations. A broader comprehension of the roles of classical...
4.
Mosarla R, Ahmed H, Rao S, Kadosh B, Cruz J, Goldberg R, et al.
J Invasive Cardiol . 2024 Aug; 37(1). PMID: 39150435
No abstract available.
5.
Lonze B, Spiegler P, Wesson R, Alachkar N, Petkova E, Weldon E, et al.
Crit Care Med . 2022 May; 50(9):1348-1359. PMID: 35583232
Objectives: We designed this study to test whether clazakizumab, a direct interleukin-6 inhibitor, benefits patients hospitalized with severe or critical COVID-19 disease accompanied by hyperinflammation. Design: Multicenter, randomized, double-blinded, placebo-controlled,...
6.
Lonze B, Baptiste G, Ali N, Dagher N, Gelb B, Mattoo A, et al.
Am J Transplant . 2020 Dec; 21(5):1931-1936. PMID: 33346951
Despite utilization of hepatitis C viremic organs for hepatitis C naïve recipients (HCV D+/R-) in other solid organ transplants, HCV viremic pancreata remain an unexplored source of donor organs. This...
7.
Araten D, Belmont H, Schaefer-Cutillo J, Iyengar A, Mattoo A, Reddy R
Am J Case Rep . 2020 Sep; 21:e927418. PMID: 32917848
BACKGROUND Patients receiving immunosuppressive therapies might be more susceptible to COVID-19. Conversely, an exaggerated inflammatory response to the SARS-CoV-2 infection might be blunted by certain forms of immunosuppression, which could...